Skip to content
10-Q

Quarterly Report

CNS Pharmaceuticals, Inc. CNSP

0001683168-25-006162

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 14, 2025 574.58K sh
Shares Diluted Q2 2025 · Jun 30, 2025 370.13K sh
Shares Diluted Q2 2025 · Jun 30, 2025 298.78K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 625 sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 457 sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$8.59M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.84M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $12.13M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $6.46M
Stockholders Equity Q2 2025 · Jun 30, 2025 $13.12M
Stockholders Equity Q2 2025 · Mar 31, 2025 $10.97M
Stockholders Equity Q2 2025 · Dec 31, 2024 $6.18M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$4.29M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$4.43M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$4.43M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.38M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.52M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.38M
Total Liabilities Q2 2025 · Dec 31, 2024 $2.52M
Current Assets Q2 2025 · Jun 30, 2025 $14.14M
Current Assets Q2 2025 · Dec 31, 2024 $8.66M
Total Assets Q2 2025 · Jun 30, 2025 $14.51M
Total Assets Q2 2025 · Dec 31, 2024 $8.7M
Eps Diluted Q2 2025 · Jun 30, 2025 −$6.42
Eps Diluted Q2 2025 · Jun 30, 2025 −$22.35
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4,049.20
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$13,294.31
Eps Basic Q2 2025 · Jun 30, 2025 −$6.42
Eps Basic Q2 2025 · Jun 30, 2025 −$22.35
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4,049.20
Eps Basic restated Q2 2025 · Jun 30, 2024 −$13,294.31
Sga Expense Q2 2025 · Jun 30, 2025 $1.24M
Sga Expense Q2 2025 · Jun 30, 2025 $2.34M
Sga Expense Q2 2025 · Jun 30, 2024 $1.41M
Sga Expense Q2 2025 · Jun 30, 2024 $2.53M
Rd Expense Q2 2025 · Jun 30, 2025 $1.17M
Rd Expense Q2 2025 · Jun 30, 2025 $4.41M
Rd Expense Q2 2025 · Jun 30, 2024 $1.12M
Rd Expense Q2 2025 · Jun 30, 2024 $3.55M
Net Income Q2 2025 · Jun 30, 2025 −$2.37M
Net Income Q2 2025 · Jun 30, 2025 −$6.68M
Net Income Q2 2025 · Mar 31, 2025 −$4.3M
Net Income Q2 2025 · Jun 30, 2024 −$2.53M
Net Income Q2 2025 · Jun 30, 2024 −$6.08M
Net Income Q2 2025 · Mar 31, 2024 −$3.54M
Operating Income Q2 2025 · Jun 30, 2025 −$2.41M
Operating Income Q2 2025 · Jun 30, 2025 −$6.75M
Operating Income Q2 2025 · Jun 30, 2024 −$2.53M
Operating Income Q2 2025 · Jun 30, 2024 −$6.07M